Is there disease progression in patients who are hepatitis C virus antibody–positive and hepatitis C virus RNA–seronegative?
✍ Scribed by Russell H. Wiesner
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 57 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We read with interest the article by Hoare et al. 1 published recently in HEPATOLOGY. Hoare et al. reported that patients who are seropositive aviremic for hepatitis C can be considered likely positive for the virus on the basis of histological changes. The retrospective study initially involved a r
The recent identification of the hepatitis C virus and development of assays to detect antibodies to hepatitis C virus has allowed assessment of the prevalence of hepatitis C virus infection in patients with a variety of liver and other diseases. The aim of this study was to investigate the prevalen
## Abstract The prevalence and the characteristics of hepatitis C virus infection (HCV) in 161 HIV‐positive patients were studied. HCV seroprevalence was determined by enzyme immunoassay and recombinant immunoblot assay (RIBA). Two different reverse transcriptase polymerase chain reaction (RT‐PCR)
We compared characteristics of patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA to those of patients with GBV-C/HGV E2-antibody. GBV-C/HGV RNA and GBV-C/HGV antibody were assayed in 83 persons with hemophilia using a reverse transcription-polymerase chain reaction and an enzyme-linked immu